• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.01%

    Orexigen Therapeutics, Inc. (OREX)

    -NasdaqGS
    4.00 Jul 31, 4:00PM EDT
    Add to Portfolio
    Prev Close:4.00
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:11.33
    Beta:1.63
    Next Earnings Date: 6-Aug-15OREX Earnings announcement
    Day's Range:N/A - N/A
    52wk Range:3.11 - 9.37
    Volume:0
    Avg Vol (3m):2,628,850
    Market Cap:500.88M
    P/E (ttm):N/A
    EPS (ttm):-0.25
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OREX

    Comparison

    Symbol% ChgMkt Cap
    OREX 0.00%500.88M
    ABT75.47B
    GSK104.91B
    RHHBY245.91B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):8.49
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.53
    Quarterly EPS Est (Jun-15) :-0.17
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):0.09

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products in the United States. The company offers Contrave for the treatment of obesity. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback